ZyVersa Therapeutics, Inc.
ZVSA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001859007
No open-market purchases or sales by ZyVersa Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of ZVSA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ZyVersa Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of ZyVersa Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on ZyVersa Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20259:25 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%416.8K shares | −5.00 ppfrom 9.99%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:09 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%285.0K shares | New | Mar 31, 2025 | SEC |
| Mar 11, 2022 | Saba Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Lighthouse Investment Partners, LLC | 13GOld format | – | New | – | SEC |
| Feb 9, 2022 | Yakira Capital Management, Inc. | 13GOld format | – | New | – | SEC |
| Feb 3, 2022 | Hudson Bay Capital Management LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ZyVersa Therapeutics, Inc. shares.
No Form 144 notices for ZyVersa Therapeutics, Inc. are on file.